awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q38928938-389E4DB7-A3A7-4907-8891-9FF25CEC3D89
Q38928938-389E4DB7-A3A7-4907-8891-9FF25CEC3D89
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38928938-389E4DB7-A3A7-4907-8891-9FF25CEC3D89
Immunosenescence: limitations of natural killer cell-based cancer immunotherapy.
P2860
Q38928938-389E4DB7-A3A7-4907-8891-9FF25CEC3D89
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38928938-389E4DB7-A3A7-4907-8891-9FF25CEC3D89
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
2f931169490eec2f20cf9daa75f1944069a847e2
P2860
A phase II trial of pan-KIR2D blockade with IPH2101 in smoldering multiple myeloma.